Archive for the ‘Lymphoma / Leukemia’ Category
Friday, April 11th, 2008
Meridian Bioscience, Inc. (NASDAQ: VIVO) announced that it has launched two new rapid tests for Epstein-Barr Virus (EBV): TRU EBV-M™ and TRU EBV-G™. The TRU EBV tests are the first rapid tests on the market which employ recombinant antigen technology to detect IgM and IgG antibodies specific to EBV. EBV ...
Posted in Lymphoma / Leukemia | No Comments »
Friday, April 11th, 2008
Compounds known as "HDAC inhibitors" exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear.In a pair of recent papers, Vanderbilt-Ingram Cancer Center investigators provide a potential mechanism by which HDAC inhibitors specifically damage ...
Posted in Lymphoma / Leukemia | No Comments »
Friday, April 11th, 2008
Genitope Corporation (Genitope, NASDAQ: GTOP) announced that a summary of the data from its pivotal Phase 3 clinical trial examining the use of MyVax® personalized immunotherapy (MyVax) in previously untreated follicular B-cell non-Hodgkin's lymphoma (fNHL) patients is available on the Investor Relations section of Genitope's Web site at http://ir.genitope.com. In ...
Posted in Lymphoma / Leukemia | No Comments »
Friday, April 11th, 2008
Researchers from the University of Pennsylvania School of Medicine and colleagues discovered that the Notch signaling pathway, which determines the development of many cell types, and is also implicated in some cancers, is not universally essential for the maintenance of stem cells. The findings appear this week in Cell Stem ...
Posted in Lymphoma / Leukemia | No Comments »
Sunday, April 6th, 2008
Non-Hodgkin lymphoma is one of the most rapidly increasing types of cancer diagnosed in the United States with new diagnoses having more than doubled since the 1970s. However, over the past 10 years, mortality rates have begun to decline, indicating that progress is being made in its treatment.According to the ...
Posted in Lymphoma / Leukemia | No Comments »
Thursday, April 3rd, 2008
A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12)."We found that lower levels of the protein interleukin-12, involved in fighting intracellular infections, increases susceptibility to young adult Hodgkin lymphoma," says Wendy ...
Posted in Lymphoma / Leukemia | No Comments »
Wednesday, April 2nd, 2008
Identifying genes that are important in specific tissues or processes in the mouse used to be a monumental task. New technologies and strategies have simplified this search, making it effective for even the smallest laboratories. This month's issue of Cold Spring Harbor Protocols (http://www.cshprotocols.org/TOCs/toc4_08.dtl) highlights a method for screening the ...
Posted in Lymphoma / Leukemia | No Comments »
Tuesday, April 1st, 2008
Survival rates of childhood cancers, especially leukemia, have improved greatly in the past three decades, but survivors of this disease still seem to face many health and lifestyle challenges as young adults. Depending on the extent of their disease and treatment methods, many continue to struggle with one ...
Posted in Lymphoma / Leukemia | No Comments »
Monday, March 31st, 2008
Leukaemia Research is celebrating having raised ￡500,000 in record time, thanks to the support of Argos employees and customers. Just seven months into the year-long charity partnership, Argos have raised enough funds to support a special cytogenetic database, which will record symptoms and treatments of different types of blood cancer ...
Posted in Lymphoma / Leukemia | No Comments »
Tuesday, March 25th, 2008
Oregon Health & Science University Cancer Institute researchers have found that an experimental drug known as SGX393 is effective against Gleevec-resistant chronic myeloid leukemia (CML). The results of their study will be published the week of March 24th in the Proceedings of the National Academy of Sciences.Gleevec, the targeted therapy ...
Posted in Lymphoma / Leukemia | No Comments »